Skip to main content

Alladapt Immunotherapeutics

Menlo Park, United States

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.

$50.0M raised
Aug 2022
Debt Financing

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alladapt Immunotherapeutics

How much funding has Alladapt Immunotherapeutics raised?
Alladapt Immunotherapeutics has raised $50.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2022.
Who are Alladapt Immunotherapeutics's investors?
Alladapt Immunotherapeutics's investors include Novartis, Patient Square Capital, Hercules Capital, Red Tree Venture Capital, Anne Wojcicki.
Where is Alladapt Immunotherapeutics headquartered?
Alladapt Immunotherapeutics is headquartered in Menlo Park, United States.
What does Alladapt Immunotherapeutics do?
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
What stage is Alladapt Immunotherapeutics at?
Alladapt Immunotherapeutics is at the Debt Financing stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alladapt Immunotherapeutics — Funding & Investors." VCBacked, August 30, 2022, https://www.vcbacked.co/company/alladapt-immunotherapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Alladapt Immunotherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/alladapt-immunotherapeutics
Wikipedia (cite web)
{{cite web |title=Alladapt Immunotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alladapt-immunotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .